Delivery Order SPE2DB20D1109-SPE2DB25FP65Z
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Cefazolin 2 G/50 ML in dextrose solution, valued at $1,200.22. This firm fixed price delivery order, which will be completed by August 13, 2025, represents a pediatric or small-volume pharmaceutical procurement with performance in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting open competition among qualified...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,047.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous formulation. This non-set-aside competitive award is set for ultimate completion by August 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $6,142.80 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextroses on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is a Firm Fixed Price Delivery Order for the supply of cefazolin 2 g/50 ml-dextrose medical products. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,373.84 for Cefazolin 1 GM vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.50 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextrose solution. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on February 20, 2025, with an ultimate completion date of February 21, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,025.80 to AmerisourceBergen Drug Corp for the supply of Cefazolin 1 G/50 ML with dextroses. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP65ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Cefazolin 2 G/50 ML with dextrose solution, valued at $2,200.41. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The award utilized no set-aside designation, indicating competitive procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle extending through December 2026. As a child contract, this delivery order exemplifies the broader relationship between the Defense Logistics Agency and one of the federal government's primary pharmaceutical distributors for military healthcare systems. AmerisourceBergen's extensive federal contracting portfolio demonstrates its critical role in supplying medications, vaccines, and medical supplies across multiple therapeutic domains to support defense and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/28/25 |